Owkin is a French-American artificial intelligence and biotech company that uses AI to analyze multimodal patient data. Its mission is to identify new treatments, optimize clinical trials, and develop AI diagnostics, particularly in precision medicine and oncology, to accelerate drug discovery and improve patient outcomes. The company aims to build the first Biology AI System (BASI) to unlock breakthroughs in therapies, diagnostics, and rejuvenation.